Home › Osteosarcoma › Connecticut
Osteosarcoma clinical trials in Connecticut
4 studies for Osteosarcoma are looking for participants at sites in Connecticut.
Cities in Connecticut
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Connecticut Children's Hospital, Hartford
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Sep 3, 2026 · NCT06541262Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Connecticut Children's Hospital, Hartford
RecruitingPhase 1/2
Up to age 26 · All sexes · Updated Sep 3, 2026 · NCT06465199Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Connecticut Children's Medical Center, Hartford
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Yale University, New Haven
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.